EGM
CRDF icon

Engineers Gate Manager’s Cardiff Oncology CRDF Stock Holding History

Engineers Gate Manager’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,585
Closed -$42.8K – 2224
2025
Q2 		$42.8K Buy
+13,585
New +$41.4K ﹤0.01% 2057
2022
Q2 		– Sell
-245,567
Closed -$609K – 1968
2022
Q1 		$609K Buy
+245,567
New +$869K 0.02% 955
2021
Q3 		– Sell
-20,109
Closed -$134K – 1694
2021
Q2 		$134K Sell
20,109
-62,304
-76% -$528K 0.01% 1462
2021
Q1 		$763K Buy
+82,413
New +$1M 0.04% 722

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Engineers Gate Manager's CRDF Position: Q3 2025 in Review

Engineers Gate Manager sold out of Cardiff Oncology (CRDF) in Q3 2025, closing a stake of 13,585 shares — an estimated $42.8K sold.

Engineers Gate Manager first reported a position in CRDF in Q1 2021 and held it in 4 quarters. The position peaked at $763K in Q1 2021. 112 funds tracked by Wall St. Rank hold CRDF as of Q3 2025.

  • Engineers Gate Manager reported no remaining Cardiff Oncology position as of Q3 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 13,585 Cardiff Oncology shares in Q3 2025, an estimated $42.8K.
  • Engineers Gate Manager first reported a position in Cardiff Oncology in Q1 2021 and held it in 4 quarters.
  • Engineers Gate Manager's Cardiff Oncology position peaked at $763K in Q1 2021.
  • 112 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2025.

Based on Engineers Gate Manager's 13F filing for Q3 2025, filed 14 Nov 2025.